The National Institute for Biotechnology in the Negev Ltd.
发明人:
申请号:
EP16872557.0
公开号:
EP3387012A4
申请日:
2016.12.08
申请国别(地区):
EP
年份:
2019
代理人:
摘要:
Variants of amyloid β-protein precursor inhibitor domain (APPI), effective in inhibiting mesotrypsin and/or kallikrein-6, and composition comprising same, are provided. Further, methods of use of said peptides or composition, including, but not limited to treatment of cancer are provided.